{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:47Z","timestamp":1786649927005,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Heart disease in pregnancy possesses a great haemodynamic challenge and is a known risk for increased maternal morbidity and mortality. The functional status of the patient is one of the most significant parameters which can impact the feto-maternal outcome. Many predictors have been studied and compiled in various scoring systems time and again. The most updated and validated is the modified WHO classification, according to which the presence of pulmonary artery hypertension (PAH) and severe ventricular dysfunction (ejection fraction &lt;30%) mandates the patient to be under class IV, which along with another important risk factor, i.e., New York heart association (NYHA) class, is revaluated under the present study. The objective of this study is to examine three of the most important predictors of adverse outcomes, i.e., functional status (NYHA class), PAH, and left ventricular ejection fraction (LVEF) in patients with heart disease in pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>It\u2019s a prospective study from January 2016 to August 2017 wherein pregnant patients with heart disease were divided on the basis of NYHA class, PAH, and LVEF, and the feto-maternal outcome was recorded and evaluated in terms of maternal mortality, fetal demise, the occurrence of major cardiac complication, and risk of preterm delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of three out of 29 (10.34%) maternal deaths were attributed to a cardiac cause. 5.45% of patients with heart disease had maternal mortality, which is in contrast to the 1.12% maternal mortality rate in general at our centre. Three out of 17 (17.64%) patients in NYHA classes 3 and 4 ended in maternal deaths, while there were no mortalities in classes 1 and 2. Intrauterine fetal demise (23.52%), risk of preterm delivery (relative risk = 0.4688; 95% CI: 0.2320 to 0.9470) was significantly higher in patients belonging to NYHA classes 3 and 4 as compared to those in classes 1 and 2. All of the ten (100%) patients who developed cardiac complications belonged to classes 3 and 4. The percentage of abortions (20.00%), intra uterine fetal demise (IUFD) (40.00%), and cardiac complication (80%) in patients with LVEF &lt;44% were significantly more than in patients with better ejection fraction. Pulmonary artery systolic pressure (PASP) \u2265 is associated with higher maternal mortality, a greater number of abortions and IUFD (22.62%), cardiac complication (22.72%), and increased risk of preterm birth (0.5769; 95% CI: 0.2801 to 1.188), but these associations are not found to be significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>NYHA class was found to be a very strong predictor followed by left ventricular ejection fraction for poor outcome. Maternal mortality in asymptomatic patients or patients with mild symptoms (NYHA classes 1 and 2) is comparable to that found in the general population. However, pulmonary artery systolic pressure is not found to be significantly associated with worse outcomes in our study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_1877_21","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:25:32Z","timestamp":1671607532000},"page":"6752-6758","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Maternal mortality and predictors of adverse outcome in patients with heart disease in pregnancy"],"prefix":"10.4103","volume":"11","author":[{"given":"Nalini","family":"Sharma","sequence":"first","affiliation":[{"name":"Assistant Professor, Department of Obstetrics and Gynaecology, NEIGRIHMS, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Senior Resident, Department of Obstetrics and Gynaecology, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rituparna","family":"Das","sequence":"additional","affiliation":[{"name":"Assistant Professor, Department of Obstetrics and Gynaecology, NEIGRIHMS, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Jethani","sequence":"additional","affiliation":[{"name":"Senior Resident Gynecological Oncology, Dr. B Borooah Cancer Institute, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrat","family":"Panda","sequence":"additional","affiliation":[{"name":"Associate Professor, Department of Obstetrics and Gynaecology, NEIGRIHMS, Shillong, Meghalaya, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9378(81)90400-2","article-title":"Pregnancy complicated by maternal heart disease at the national maternity hospital. Dublin, Ireland. 1969 to 1978","volume":"139","author":"Sugrue","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.ogx.0000418568.37021.b9","article-title":"The contribution of heart disease to pregnancy-related mortality according to the pregnancy mortality surveillance system","volume":"67","author":"Burlingame","year":"2012","journal-title":"Obstet Gynecol Surv"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC guidelines on the management of cardiovascular diseases during pregnancy:The task force on the management of cardiovascular diseases during pregnancy of the European society of cardiology (ESC)","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur Heart J"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/hc3001.093437","article-title":"Prospective multicenter study of pregnancy outcomes in women with heart disease","volume":"104","author":"Siu","year":"2001","journal-title":"Circulation"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2018.02.076","article-title":"Pregnancy outcomes in women with heart disease:The CARPREG II study","volume":"71","author":"Silversides","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13224-012-0220-2","article-title":"Pregnancy complicated by maternal heart disease:A review of 281 women","volume":"62","author":"Konar","year":"2012","journal-title":"J Obstet Gynecol India"},{"key":"R8-20260109","first-page":"25","article-title":"Clinical study of heart disease complicating pregnancy","volume":"2","author":"Bangal","year":"2012","journal-title":"IOSR"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1590\/S0066-782X2000000900003","article-title":"Prognostic factors of rheumatic mitral stenosis during pregnancy and puerperium","volume":"75","author":"Barbosa","year":"2000","journal-title":"Arq Bras Cardiol"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0020-7292(02)00029-2","article-title":"Maternal and perinatal outcome in rheumatic heart disease","volume":"80","author":"Sawhney","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"R12-20260109","first-page":"7","article-title":"Maternal heart disease and pregnancy outcomes","volume":"15","author":"Puri","year":"2013","journal-title":"JK Sci"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/heartasia-2013-010396","article-title":"Pregnancy complicated by heart disease in Nepal","volume":"6","author":"Chhetri","year":"2014","journal-title":"Heart Asia"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0002-9378(87)90275-4","article-title":"Congenital heart disease in pregnancy:Short and long term implications","volume":"156","author":"Shime","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1161\/01.CIR.96.9.2789","article-title":"Risk and predictors for pregnancy-related complications in women with heart disease","volume":"96","author":"Siu","year":"1997","journal-title":"Circulation"},{"key":"R16-20260109","first-page":"35","article-title":"Risk of warfarin during pregnancy with mechanical valve prostheses","volume":"99","author":"Cotrufo","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-0528.1988.tb06570.x","article-title":"Pregnancy complicated by maternal heart disease","volume":"95","author":"McFaul","year":"1988","journal-title":"A review of 519 women. Br J Obstet Gynaecol"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ejheart.2008.07.017","article-title":"Maternal heart disease and pregnancy outcome:A single-centre experience","volume":"10","author":"Stangl","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12872-018-0856-7","article-title":"Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy","volume":"18","author":"Yam\u00e9ogo","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/heartjnl-2013-304888","article-title":"Heart failure in pregnant women with cardiac disease:Data from the ROPAC","volume":"100","author":"Ruys","year":"2014","journal-title":"Heart"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/eurheartj\/ehn597","article-title":"Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?","volume":"30","author":"Bedard","year":"2009","journal-title":"Eur Heart J"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ejhf.594","article-title":"Pulmonary hypertension and pregnancy outcomes:Data from the registry of pregnancy and cardiac disease (ROPAC) of the European Society of Cardiology","volume":"18","author":"Sliwa","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0735-1097(98)00162-4","article-title":"Outcome of pulmonary vascular disease in pregnancy:A systematic overview from 1978 through 1996","volume":"31","author":"Weiss","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R24-20260109","doi-asserted-by":"crossref","first-page":"e006144","DOI":"10.1161\/JAHA.117.006144","article-title":"Pulmonary hypertension and pregnancy outcomes:Insights from the national inpatient sample","volume":"6","author":"Thomas","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R25-20260109","first-page":"16","article-title":"The spectrum of heart disease in pregnancy and its outcome in patients visiting a tertiary care centre of Northeastern:A prospective study","volume":"12","author":"Khan","year":"2018","journal-title":"J Clin Diagn Res"},{"key":"R26-20260109","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1136\/heartjnl-2019-314702","article-title":"Pregnancy in congenital heart disease:Risk prediction and counselling","volume":"106","author":"van Hagen","year":"2020","journal-title":"Heart"},{"key":"R27-20260109","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice:The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention &Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"R28-20260109","first-page":"63","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk:A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"2014","author":"Eckel","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R29-20260109","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body fat distribution and risk of cardiovascular disease:An update","volume":"126","author":"Despres","year":"2012","journal-title":"Circulation"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1877_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:00:03Z","timestamp":1786647603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_1877_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1877_21","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"2021-09-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}